Therefore, we postulated that GOLIM4 activates protumorigenic secretory processes and tested this hypothesis by carrying out immunohistochemical studies on GOLIM4-deficient and -replete tumors, which showed that GOLIM4 deficiency reduced endothelial cell numbers in tumor stroma (Figure 3A). Here, GOLIM4 is linked to neoplasm.